Lv3
260 积分 2024-07-02 加入
Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review
6天前
已完结
Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation
6天前
已完结
Injectability as a function of viscosity and dosing materials for subcutaneous administration
6天前
已完结
Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
6天前
已完结
Differences Between Intravenous and Subcutaneous Modes of Administration in Oncology from the Patient, Healthcare Provider, and Healthcare System Perspectives: A Systematic Review
6天前
已完结
CMC Considerations for Continuous Bioprocess Design, Development, and Manufacturing
21天前
已完结
Role of Formulation Parameters on Intravitreal Dosing Accuracy Using 1 mL Hypodermic Syringes
21天前
已完结
Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish
24天前
已关闭
Developing ultra-high concentration formulations of human immune globulins for subcutaneous injectables
1个月前
已完结
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
1个月前
已完结
皖公网安备34019202002308
